182 related articles for article (PubMed ID: 8536452)
41. Oral contraceptives and breast cancer.
Brinton LA; Hoover R; Szklo M; Fraumeni JF
Int J Epidemiol; 1982 Dec; 11(4):316-22. PubMed ID: 7152784
[TBL] [Abstract][Full Text] [Related]
42. Clinical comparison of two low-dose oral contraceptives, Minulet and Mercilon, in women over 30 years of age.
Kirkman RJ; Pedersen JH; Fioretti P; Roberts HE
Contraception; 1994 Jan; 49(1):33-46. PubMed ID: 8137624
[TBL] [Abstract][Full Text] [Related]
43. The influence of thrombotic risk factors when oral contraceptives are prescribed. A control-only study.
Lidegaard O
Acta Obstet Gynecol Scand; 1997 Mar; 76(3):252-60. PubMed ID: 9093141
[TBL] [Abstract][Full Text] [Related]
44. Sexual and reproductive life events in relation to duration of oral contraceptive use.
Lidegaard O; Helm P
Contraception; 1988 Jul; 38(1):69-77. PubMed ID: 3168446
[TBL] [Abstract][Full Text] [Related]
45. Oral contraceptives and breast cancer: latest findings in a large cohort study.
Vessey MP; McPherson K; Villard-Mackintosh L; Yeates D
Br J Cancer; 1989 Apr; 59(4):613-7. PubMed ID: 2713247
[TBL] [Abstract][Full Text] [Related]
46. The safety of oral contraceptives: epidemiologic insights from the first 30 years.
Grimes DA
Am J Obstet Gynecol; 1992 Jun; 166(6 Pt 2):1950-4. PubMed ID: 1605284
[TBL] [Abstract][Full Text] [Related]
47. Oral contraceptives and breast cancer in young women.
Stadel BV; Rubin GL; Webster LA; Schlesselman JJ; Wingo PA
Lancet; 1985 Nov; 2(8462):970-3. PubMed ID: 2865503
[TBL] [Abstract][Full Text] [Related]
48. Immunogenicity and the vascular risk of oral contraceptives.
Plowright C; Adam SA; Thorogood M; Beaumont V; Beaumont JL; Mann JI
Br Heart J; 1985 May; 53(5):556-61. PubMed ID: 3994871
[TBL] [Abstract][Full Text] [Related]
49. Neoplasia of the cervix uteri and contraception: a possible adverse effect of the pill.
Vessey MP; Lawless M; McPherson K; Yeates D
Lancet; 1983 Oct; 2(8356):930-4. PubMed ID: 6138502
[TBL] [Abstract][Full Text] [Related]
50. Oral contraceptives and breast cancer.
Jick H; Walker AM; Watkins RN; D'Ewart DC; Hunter JR; Danford A; Madsen S; Dinan BJ; Rothman KJ
Am J Epidemiol; 1980 Nov; 112(5):577-85. PubMed ID: 7435486
[TBL] [Abstract][Full Text] [Related]
51. Worldwide variations in the lifetime probability of reproductive cancer in women: implications of best-case, worst-case, and likely-case assumptions about the effect of oral contraceptive use.
Petitti DB; Porterfield D
Contraception; 1992 Feb; 45(2):93-104. PubMed ID: 1559340
[TBL] [Abstract][Full Text] [Related]
52. Choice of contraceptive modality by women in Norway.
Skjeldestad FE
Acta Obstet Gynecol Scand; 1994 Jan; 73(1):48-52. PubMed ID: 8304025
[TBL] [Abstract][Full Text] [Related]
53. Risk of idiopathic cardiovascular death and nonfatal venous thromboembolism in women using oral contraceptives with differing progestagen components.
Jick H; Jick SS; Gurewich V; Myers MW; Vasilakis C
Lancet; 1995 Dec; 346(8990):1589-93. PubMed ID: 7500750
[TBL] [Abstract][Full Text] [Related]
54. Women's knowledge of taking oral contraceptive pills correctly and of emergency contraception: effect of providing information leaflets in general practice.
Smith LF; Whitfield MJ
Br J Gen Pract; 1995 Aug; 45(397):409-14. PubMed ID: 7576845
[TBL] [Abstract][Full Text] [Related]
55. Oral contraceptives and reproductive factors in multiple sclerosis incidence.
Villard-Mackintosh L; Vessey MP
Contraception; 1993 Feb; 47(2):161-8. PubMed ID: 8449016
[TBL] [Abstract][Full Text] [Related]
56. Effects of oral contraceptives on hemostasis and thrombosis.
Rosing J; Tans G
Am J Obstet Gynecol; 1999 Jun; 180(6 Pt 2):S375-82. PubMed ID: 10368524
[TBL] [Abstract][Full Text] [Related]
57. Contraceptive use projections: 1990 to 2010.
Trussell J; Vaughan B
Am J Obstet Gynecol; 1992 Oct; 167(4 Pt 2):1160-4. PubMed ID: 1415440
[TBL] [Abstract][Full Text] [Related]
58. Breast cancer among young U.S. women in relation to oral contraceptive use.
White E; Malone KE; Weiss NS; Daling JR
J Natl Cancer Inst; 1994 Apr; 86(7):505-14. PubMed ID: 8133534
[TBL] [Abstract][Full Text] [Related]
59. Contraceptive steroid effects on nonreproductive organ systems.
Corson SL
J Reprod Med; 1986 Sep; 31(9 Suppl):865-78. PubMed ID: 3772906
[TBL] [Abstract][Full Text] [Related]
60. Early oral contraceptive use and breast cancer among premenopausal women: final report from a study in southern Sweden.
Olsson H; Möller TR; Ranstam J
J Natl Cancer Inst; 1989 Jul; 81(13):1000-4. PubMed ID: 2733043
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
